A Safety and Efficacy Study of MSI-1256F (Squalamine Lactate) To Treat "Wet" Age-Related Macular Degeneration
Clinical trial NCT00089830 · TERMINATED
Trial details
- NCT number
- NCT00089830
- Sponsor
- Genaera Corporation
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-08-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.